Literature DB >> 34362795

N6 -methyladenosine-Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression.

Junge Deng1, Jialiang Zhang1, Ying Ye1, Kaijing Liu1, Lingxing Zeng1, Jingyi Huang1, Ling Pan1, Mei Li2, Ruihong Bai1, Lisha Zhuang1, Xudong Huang1, Guandi Wu1, Lusheng Wei3, Yanfen Zheng1, Jiachun Su1, Shaoping Zhang1, Rufu Chen4, Dongxin Lin5,6,7, Jian Zheng5,7.   

Abstract

Pseudogenes may play important roles in cancer. Here, we explore the mechanism and function of a pseudogene WTAPP1 in the progress of pancreatic ductal adenocarcinoma (PDAC). WTAPP1 RNA was significantly elevated in PDAC and was associated with poor prognosis in patients. Overexpression of WTAPP1 RNA promoted PDAC proliferation and invasiveness in vitro and in vivo. Mechanistically, N 6-methyladenosine (m6A) modification stabilized WTAPP1 RNA via CCHC-type zinc finger nucleic-acid binding protein (CNBP), resulting in increased levels of WTAPP1 RNA in PDAC cells. Excessive WTAPP1 RNA bound its protein-coding counterpart WT1-associated protein (WTAP) mRNA and recruited more EIF3 translation initiation complex to promote WTAP translation. Increased WTAP protein enhanced the activation of Wnt signaling and provoked the malignant phenotypes of PDAC. Decreasing WTAPP1 RNA significantly suppressed the in vivo growth and metastasis of PDAC cell lines and patient-derived xenografts. These results indicate that m6A-mediated increases in WTAPP1 expression promote PDAC progression and thus may serve as a therapeutic target. SIGNIFICANCE: This study reveals how aberrant m6A modification of the WTAPP1 pseudogene results in increased translation of its protein-coding counterpart to promote Wnt signaling, which contributes to pancreatic cancer progression. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34362795     DOI: 10.1158/0008-5472.CAN-21-0494

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.

Authors:  Yu Zhang; Xiaoxiao Tian; Yanli Bai; Xianmin Liu; Jingjing Zhu; Lamei Zhang; Jinliang Wang
Journal:  Mamm Genome       Date:  2022-09-29       Impact factor: 3.224

2.  Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-β and enhances chemoradiotherapy resistance.

Authors:  Yu Liu; Mingxu Da
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-28       Impact factor: 4.322

Review 3.  Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.

Authors:  Qiang Liu
Journal:  Front Genet       Date:  2022-01-11       Impact factor: 4.599

Review 4.  N6 -Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review.

Authors:  Sha Wu; Xiao-Feng Li; Yuan-Yuan Wu; Su-Qin Yin; Cheng Huang; Jun Li
Journal:  Front Immunol       Date:  2021-09-24       Impact factor: 7.561

Review 5.  m6A modification: recent advances, anticancer targeted drug discovery and beyond.

Authors:  Li-Juan Deng; Wei-Qing Deng; Shu-Ran Fan; Min-Feng Chen; Ming Qi; Wen-Yu Lyu; Qi Qi; Amit K Tiwari; Jia-Xu Chen; Dong-Mei Zhang; Zhe-Sheng Chen
Journal:  Mol Cancer       Date:  2022-02-14       Impact factor: 27.401

Review 6.  The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer.

Authors:  Chao-Yue Sun; Di Cao; Bin-Bin Du; Cun-Wu Chen; Dong Liu
Journal:  Int J Biol Sci       Date:  2022-03-28       Impact factor: 10.750

Review 7.  The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.

Authors:  Xiaoge Hu; Xiangxiang Lei; Jinhui Guo; Wen Fu; Wen Sun; Qiliang Lu; Wei Su; Qiuran Xu; Kangsheng Tu
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

Review 8.  Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.

Authors:  Sai Chen; Hefei Ren; Xiaomin Zhang; Liu Chang; Zhenhua Wang; Hongkun Wu; Jiafeng Zhang; Jigang Ren; Lin Zhou
Journal:  J Clin Lab Anal       Date:  2022-07-15       Impact factor: 3.124

Review 9.  Role of m6A writers, erasers and readers in cancer.

Authors:  Zhen Fang; Wentong Mei; Chang Qu; Jiongdi Lu; Liang Shang; Feng Cao; Fei Li
Journal:  Exp Hematol Oncol       Date:  2022-08-09

Review 10.  Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.

Authors:  Yongfei Fan; Xinwei Li; Huihui Sun; Zhaojia Gao; Zheng Zhu; Kai Yuan
Journal:  Biomolecules       Date:  2022-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.